|Articles|June 3, 2015
Video, enVista® IOL in Oculocutaneous Albinism Patient
In this educational video, Anil Shivaram, MD of Claremont Eye Associates implants the enVista® IOL from Bausch + Lomb in a patient with type 1 oculocutaneous albinism utilizing the Stellaris® Vision Enhancement System and Storz CapsuleGuard IA handpiece.
Advertisement
In this educational video, Anil Shivaram, MD of Claremont Eye Associates implants the enVista® IOL from Bausch + Lomb in a patient with type 1 oculocutaneous albinism utilizing the Stellaris® Vision Enhancement System and Storz CapsuleGuard IA handpiece.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Metformin use associated with reduced incidence of intermediate AMD
2
MeiraGTx Licenses complement-targeted geographic atrophy program from ZipBio
3
Looking back at the 2025 EnVision Summit
4
Last year in glaucoma at EnVision Summit 2025
5
























